Skip to main content
Fig. 4 | Clinical Proteomics

Fig. 4

From: Combination of laser microdissection, 2D-DIGE and MALDI-TOF MS to identify protein biomarkers to predict colorectal cancer spread

Fig. 4

The expression of JAG2 (A1) ADAMTS2 (B1) and NME2 (C1) of the tumour cells of stage 1, 2, 3 CRC patients in a cohort of 125 tumor tissues is associated with CRC specific survival. Strong expression of JAG2, ADAMTS2 and NME2 on cancer cells of stage 3 CRC patients showed better CRC specific survival than moderate and weak expression of the proteins respectively (A2, B2, C2)

Back to article page